Clinical Trial Update: TH-CAR-027 for Grade 4 Gliomas [EARLY_Phase 1]

View source ↗

Summary

Clinical trial update on TH-CAR-027 for recurrent/relapsed Grade 4 glioma. The study is in early Phase 1 and not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• TH-CAR-027

Snippet

Sponsor: Shanghai Tongji Hospital, Tongji University School of Medicine | Conditions: R/R Grade 4 Glioma | EARLY_Phase 1 | Status: NOT_YET_RECRUITING